CLINICAL_TRIALS
ClinicalTrials.gov record update
The Inflammasome and Dysfunctional Adipose Tissue: Why Should apoB-lipoproteins be Targeted in Humans
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT04496154
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:26:52.670599+00:00
- Published At
- 2025-02-11T00:00:00+00:00
- Record Updated At
- 2025-02-11
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Type 2 Diabetes", "Insulin Sensitivity/Resistance", "Inflammatory Response", "Fatty Acids, Omega-3"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-02-11"- protocolSection.identificationModule.nctId
"NCT04496154"- protocolSection.identificationModule.officialTitle
"The Inflammasome and Dysfunctional Adipose Tissue: Why Should apoB-lipoproteins be Targeted in Humans"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["NA"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.